Search

everythinglearnresearchcommunity

for

Search:↓

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Hormones affect skin aging, and treatments targeting hormonal balance may improve skin health.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Epithelial-mesenchymal interactions control hair growth cycles through specific molecular signals.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Oestrogens are key for bone growth during puberty in both boys and girls.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

The document concludes that understanding the sebaceous gland's development and function is key to addressing related skin diseases and aging effects.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Growth factors are crucial for hair development and could help treat hair diseases.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.